What is the official website of MSD Österreich ?

The official website of MSD Österreich is https://www.msd.at/.

What is MSD Österreich's cybersecurity risk score?

MSD Österreich has an AI-generated cybersecurity risk score of 754 out of 1000, indicating a Fair security posture according to Rankiteo's assessment.

How many security incidents has MSD Österreich experienced?

According to Rankiteo, MSD Österreich currently holds 0 security badges, indicating that no recognized compliance certifications are currently verified for the organization.

Has MSD Österreich been affected by any supply chain cyber incidents ?

According to Rankiteo, MSD Österreich has not been affected by any supply chain cyber incidents, and no incident IDs are currently listed for the organization.

Does MSD Österreich have SOC 2 Type 1 certification ?

According to Rankiteo, MSD Österreich is not certified under SOC 2 Type 1.

Does MSD Österreich have SOC 2 Type 2 certification ?

According to Rankiteo, MSD Österreich does not hold a SOC 2 Type 2 certification.

Does MSD Österreich comply with GDPR ?

According to Rankiteo, MSD Österreich is not listed as GDPR compliant.

Does MSD Österreich have PCI DSS certification ?

According to Rankiteo, MSD Österreich does not currently maintain PCI DSS compliance.

Does MSD Österreich comply with HIPAA ?

According to Rankiteo, MSD Österreich is not compliant with HIPAA regulations.

Does MSD Österreich have ISO 27001 certification ?

According to Rankiteo,MSD Österreich is not certified under ISO 27001, indicating the absence of a formally recognized information security management framework.

Which industry does MSD Österreich operate in ?

MSD Österreich operates primarily in the Pharmaceutical Manufacturing industry.

How many employees does MSD Österreich have ?

MSD Österreich employs approximately 302 people worldwide.

Does MSD Österreich own any subsidiaries ?

MSD Österreich presently has no subsidiaries across any sectors.

How many LinkedIn followers does MSD Österreich have ?

MSD Österreich's official LinkedIn profile has approximately 6,721 followers.

Does MSD Österreich have a Crunchbase profile ?

No, MSD Österreich does not have a profile on Crunchbase.

Does MSD Österreich have a LinkedIn profile ?

Yes, MSD Österreich maintains an official LinkedIn profile, which is actively utilized for branding and talent engagement, which can be accessed here: https://www.linkedin.com/company/msd-oesterreich.

How many cybersecurity incidents has MSD Österreich experienced ?

As of June 13, 2026, Rankiteo reports that MSD Österreich has experienced 1 cybersecurity incidents.

How many peer or competitor companies does MSD Österreich have ?

MSD Österreich has an estimated 5,686 peer or competitor companies worldwide.

What types of cybersecurity incidents has MSD Österreich faced ?

Incident Types: The types of cybersecurity incidents that have occurred include Breach.

NEWRankiteo Cyber Underwriting Desktop - Score, price, and bind from your desktop

WindowsmacOSLinux

Download

Badge your company to reduce your risk score and your cyber insurance costs!

Link verified badges to your company page to build trust with insurers and customers.

Apply now and get your badge!

Internal validation & live display

Insurers and partners see a safer profile

Faster underwriting decisions

Trusted by insurers. Chosen by leaders.

Proud contributor to the Society of Actuaries.

MSD Österreich

Boost Score +25 with badge (5 left)

754

/1000

Fair

779

/1000

Fair

MSD Österreich Vendor Cyber Rating & Cyber Score

msd.at

Add Your Compliance Badge

MSD – in den USA und Kanada Merck & Co., Inc., mit Sitz in Kenilworth, NJ, USA – ist ein führendes globales Gesundheitsunternehmen, das seit mehr als 126 Jahren neue Lösungen für Gesundheitsprobleme weltweit erforscht und weiterentwickelt. Das Unternehmen ist mit rund 68.000 Mitarbeitern in mehr als 140 Ländern vertreten. Im Jahr 2016 hat MSD einen Umsatz von rund 39,8 Milliarden US-Dollar erzielt und ist gemessen am Umsatz der fünftgrößte Arzneimittelhersteller weltweit (Forbes Global 2000 List 2017). In Österreich hat die Unternehmensgruppe ihren Hauptsitz in Wien. Im Kerngeschäft erforscht, entwickelt, produziert und vertreibt MSD verschreibungspflichtige Arzneimittel, Impfstoffe und Biologika sowie Präparate für die Tiergesundheit. Um

MSD Österreich A.I CyberSecurity Scoring

Scoring History

MSD Österreich

MSD Österreich CyberSecurity News & History

Past Incidents

Attack Types

Entity

Type

Severity

Impact

Seen

Blog Details

Supply Chain Source

Incident Details

View

MSD Österreich

Breach

9/2025

MSD060270611182...

Loading…

A.I.

MSD Österreich Company Scoring based on AI Models

Cyber Incidents Likelihood 3 - 6 - 9 months

Actual

Prediction

Incident Predictions locked

Access Monitoring Plan

A.I Risk Score Likelihood 3 - 6 - 9 months

Actual

Prediction A

Prediction B

Prediction C

Prediction D

A.I. Risk Score Predictions locked

Access Monitoring Plan

Loading…

Underwriter Stats for MSD Österreich

Incidents vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Österreich in 2026.

Incidents vs All-Companies Average (This Year)

No incidents recorded for MSD Österreich in 2026.

Incident Types MSD Österreich vs Pharmaceutical Manufacturing Industry Avg (This Year)

No incidents recorded for MSD Österreich in 2026.

Incident History - MSD Österreich (X = Date, Y = Severity)

Loading…

SUBSIDIARY

MSD Österreich Subsidiaries

MSD Österreich

Pharmaceutical Manufacturing

Website: https://www.msd.at/

Company Size: 302

MSDPharmaceutical Manufacturing

MSD LATAMPharmaceutical Manufacturing

MSD Animal HealthPharmaceutical Manufacturing

MSD Saúde AnimalVeterinary Services

MSD DeutschlandPharmaceutical Manufacturing

MSD FrancePharmaceutical Manufacturing

MSD EgyptPharmaceutical Manufacturing

MSD NetherlandsPharmaceutical Manufacturing

MSD EspañaPharmaceutical Manufacturing

MSD GCCPharmaceutical Manufacturing

MSD TürkiyePharmaceutical Manufacturing

MSD PortugalPharmaceutical Manufacturing

MSD ItaliaPharmaceutical Manufacturing

MSD SwitzerlandPharmaceutical Manufacturing

MSD in the UKPharmaceutical Manufacturing

MSD Australia & New ZealandPharmaceutical Manufacturing

MSD Czech RepublicPharmaceutical Manufacturing

MSD Animal Health Technology LabsTechnology, Information and Internet

MSD JordanPharmaceutical Manufacturing

MSD GreecePharmaceutical Manufacturing

MSD South AfricaPharmaceutical Manufacturing

MSD PolskaPharmaceutical Manufacturing

MSD Animal Health UK LtdPharmaceutical Manufacturing

MSD BelgiumPharmaceutical Manufacturing

MSD RomaniaPharmaceutical Manufacturing

MSD SverigePharmaceutical Manufacturing

MSD FinlandPharmaceutical Manufacturing

MSD DanmarkPharmaceutical Manufacturing

MSD NorgePharmaceutical Manufacturing

MSD LebanonPharmaceutical Manufacturing

MSD SRBIJAPharmaceutical Manufacturing

MSD MagyarországPharmaceutical Manufacturing

MSD SlovenskoPharmaceutical Manufacturing

MSD UkrainePharmaceutical Manufacturing

Loading…

MSD Österreich Similar Companies

Sandoz

sandoz.com

Sandoz is the global leader in generic and biosimilar medicines. Our Purpose is to pioneer access to medicines for patients globally. We are on a mission to drive innovation in the healthcare industry by freeing up resources sustainably and responsibly while continuing to address global health challenges such as antimicrobial resistance. We are present in more than 100 countries and our medicines serve some 500 million people every year. We have two main global businesses: Generics - divided between standard generics and complex generics - and Biosimilars. Read our community engagement guidelines: http://bit.ly/4ofoggc

MACLEODS PHARMACEUTICALS LTD.

macleodspharma.com

A vertically integrated, Global Pharmaceutical Company. Established in 1989, we are engaged in developing, manufacturing, and marketing a wide range of formulations across several major therapeutic areas including anti-infectives, cardiovascular, anti-diabetic, dermatology, and hormone treatment. We develop, manufacture, and globally distribute a broad range of pharmaceutical products across therapies in multiple dosage forms such as solid orals, liquid orals, topical formulations, injectables (Dry Powder) metered dose inhalers and dry powder inhalers. Our Vision To be a leading global pharmaceutical company by providing high quality, affordable and innovative therapeutic solutions for patients with diverse medical needs. Our Mission To contribute towards improving patients’ quality of life across the globe, by providing effective and accessible medicines.

Glenmark Pharmaceuticals

glenmarkpharma.com

Glenmark Pharmaceuticals Limited is a research-led, global organization committed to enriching lives. Innovation is deeply embedded in Glenmark’s culture; it is how we differentiate ourselves in our key markets and create greater value for our stakeholders. In our journey of innovation over the past four and a half decades, we have evolved from a generics company to a global organization offering specialty and branded products. Glenmark’s core values of Achievement, Respect, and Knowledge impart a sense of organizational unity that drives our growth. We have established a robust global branded generics, specialty, and OTC business; with a significant presence in the therapy areas of dermatology, respiratory, and oncology. Our ten state-of-the-art manufacturing facilities spread across four continents with operations in over 80 countries help us impact millions of patients across the globe. We recently consolidated our innovation efforts in small molecules and biologics research with the formation of ‘Ichnos Glenmark Innovation’ (IGI). This alliance is aimed at leveraging the capabilities of Glenmark and its subsidiary, Ichnos Sciences, to accelerate innovation in cancer treatment. To know more about IGI, check out: https://iginnovate.com/ Sustainability is an integral aspect of all our operations and we are focused on achieving our Environment, Social and Governance (ESG) goals. Our responsibility also extends to our communities, and over the years, our CSR efforts have touched the lives of over 3 million people.

MANKIND PHARMA LTD

mankindpharma.com

Mankind Pharma, one of the top 5 leading pharmaceutical companies in India, started its journey in 1995. Today, we have an employee base of over 20,000 and are racing towards $1 Billion. At Mankind, we aspire to aid the community in leading a healthy life by formulating, developing, commercializing, and delivering affordable and accessible medicines that satisfy urgent medical needs. We take great pride in the success of our products ranging from Pharma, OTC and FMCG brands like Manforce Condoms, Manforce Tablets, Manforce Staylong Gel, Unwanted 72, Prega News, Gas-O-Fast, Kaloree 1, Kabzend, Acne Star Gel and many others. Our operations are in 34 overseas destinations across Asia, Africa, South-East Asia, Gulf countries and CIS countries. Our Vision - To be a global pharmaceutical company, most admired for its Affordability, Quality and Accessibility of products. Our Mission - To be able to provide cost-effective, innovation based superior quality pharmaceutical products across the globe, to improve the lives of the patients. Mankind strongly believes and follows its Core Values: 𝐂𝐮𝐬𝐭𝐨𝐦𝐞𝐫 𝐂𝐞𝐧𝐭𝐫𝐢𝐜𝐢𝐭𝐲: Commitment to Customer - Internal and External 𝐐𝐮𝐚𝐥𝐢𝐭𝐲: It is in our DNA to maintain and deliver highest quality standards and products 𝐈𝐧𝐧𝐨𝐯𝐚𝐭𝐢𝐨𝐧: Intensely Research driven organization aiming at product innovation and technology improvements 𝐈𝐧𝐭𝐞𝐠𝐫𝐢𝐭𝐲: Always trustworthy, widely respected to be honest, and believed by everyone 𝐆𝐨 𝐁𝐞𝐲𝐨𝐧𝐝: Aim higher than capabilities 𝐏𝐞𝐨𝐩𝐥𝐞 𝐃𝐞𝐯𝐞𝐥𝐨𝐩𝐦𝐞𝐧𝐭 𝐚𝐧𝐝 𝐂𝐨𝐥𝐥𝐚𝐛𝐨𝐫𝐚𝐭𝐢𝐨𝐧: Together we are foreseeing future and diligently stimulating our people in attaining goals

Alembic Pharmaceuticals Limited

alembic-india.com

Established in 1907, Alembic Pharmaceuticals Limited is a leading pharmaceutical company in India. The Company is vertically integrated with the ability to develop, manufacture and market pharmaceutical products, pharmaceutical substances and Intermediates. Alembic is the market leader in the Macrolides segment of anti-infective drugs in India. Alembic's manufacturing facilities are located in Vadodara and Baddi in Himachal Pradesh. The plant at Vadodara has the largest fermentation capacity in India. The Panelav facility houses the API and formulation manufacturing (both US FDA approved) plants. The plant at Baddi, Himachal Pradesh manufactures formulations for the domestic and non-regulated export market. The company has a state of the art Research Centre at Vadodara.

Parexel

parexel.com

Parexel is a leading global clinical research organization (CRO) providing insights-driven Clinical and Consulting solutions to the world’s life sciences industry. Leveraging deep local knowledge and a global breadth of clinical, regulatory and therapeutic expertise, our 24,000+ professionals worldwide work in partnership with biopharmaceutical leaders, emerging innovators and sites to design and deliver clinical trials with patients in mind — broadening access and making clinical research a care option for anyone, anywhere. Our proven track record spans 40+ years and drives us forward, advancing clinical research in healthcare’s most complex areas while harnessing innovation to drive efficiencies across every phase of the clinical development process. Our insights-driven approach, proven delivery and trusted execution are accelerating the delivery of life-changing treatments to patients — With Heart.™ We continue to earn recognition industrywide, including the 2025 Scrip Award for “Best Contract Research Organization – Full-Service Provider,” 2024 Fierce Biotech CRO Award for "Innovative Approaches to Patient-Centric Research" and the 2024 and 2023 Society for Clinical Research Sites (SCRS) Eagle Award. Community Guidelines Because Parexel’s social media channels are open to the general public and employees, we are not responsible for views expressed other than our own. However, we do not tolerate posts that are: • Abusive, harassing or threatening to others. • Defamatory, offensive, obscene, vulgar or depicting violence. • Hateful targeting by race/ethnicity, age, color, creed, religion, gender, sexual preference or orientation, nationality or political beliefs. • Sexually explicit or pornographic. • Fraudulent, deceptive, libelous, misleading or unlawful. • Referencing criminal or illegal activity. • Spamming. We reserve the right to remove comments that do not adhere to our guidelines and report users who violate the rules of our page.

Catalent

catalent.com

Championing the missions that matter™. Catalent, Inc. is a leading global contract development and manufacturing organization (CDMO) and trusted partner to pharma, biotech, and consumer health companies worldwide. We put patients first in everything we do, helping people live better and healthier lives through every product we help develop, manufacture and deliver. With over 1,000 active development programs at any given time, we launch over 100 new products and line extensions annually. Catalent has supported half of all FDA approvals over the past decade, and our teams working at over 40 global sites help us produce over 60 billion doses every year. Our strength lies in our people: teams across our more than 40 sites and thousands of passionate scientists and technicians who bring expertise in development sciences, delivery technologies, and multi-modality manufacturing. What unites us is our commitment to championing our partners’ missions as our own, anticipating customer needs, solving complex challenges and ultimately making a difference in the lives of patients across the globe. At Catalent, you will be able to directly have an impact, solving problems and ensuring excellence for our customers. Our focus on delivering meaningful outcomes alongside our customers means your work directly impacts millions of people around the world. Join us in championing the missions that matter. Catalent is headquartered in Tampa, Florida, with over 40 global sites. Visit www.catalent.com to learn more.

UCB

cb ucb.com

At UCB, we believe everyone deserves to live the best life they can - as free as possible from the challenges and uncertainty of disease. Our purpose is to support people living with severe central nervous system and immunological conditions by delivering meaningful solutions that go beyond medicine. We are driven by the experiences of patients and caregivers, and inspired to pursue innovations that create real value - not just in clinical outcomes, but in everyday moments, dreams pursued, and simple pleasures enjoyed. Our ambition is to unlock transformative science and technologies that respond to unmet needs and elevate lives. From our headquarters in Belgium to nearly 40 countries around the world, we nurture a culture of respect and care. By listening deeply and collaborating across borders and disciplines, we enable cutting-edge research shaped by patients’ needs. Through strong connections with healthcare professionals, partners, and communities, we strive to make a lasting impact - today and into the future. We're inspired by patients, driven by science.

Astellas Pharma

astellas.com

Astellas is a global life sciences company committed to turning innovative science into VALUE for patients. We provide transformative therapies in disease areas that include oncology, ophthalmology, urology, immunology and women's health. Through our research and development programs, we are pioneering new healthcare solutions for diseases with high unmet medical need. Visit our Global Astellas LinkedIn Community Guidelines to learn more about interacting with this page: https://www.astellas.com/en/global-linkedin-community-guidelines

Loading…

NEWS

MSD Österreich CyberSecurity News

Latest updates, reports, and threat intel affecting the global network.

Loading…

CVE

Latest

Global CVEs (Not Company-Specific)

CVE-2026-6676

SUMMARY

Heap buffer out-of-bounds write vulnerability in Avira Antivirus engine when scanning a malformed POSIX tar archive may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.27.12.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2026-12068

SUMMARY

Information disclosure vulnerability in Avira Password Manager when used with Mozilla Firefox may allow a remote attacker operating a cross-origin iframe to obtain credentials autofilled for the parent web page via incorrect autofill field selection. This issue affects Avira Password Manager when used with Mozilla Firefox on Windows, macOS, and Linux.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.4)

cvss3

Base Score: 7.4

Complexity: LOW

CVSS:3.1/AV:N/AC:L/PR:N/UI:R/S:C/C:H/I:N/A:N

Impact Score

Exploitability

2.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2025-9033

SUMMARY

Heap buffer out-of-bounds read vulnerability in Avira Antivirus engine when scanning a malformed PDF file may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.70.76.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2025-9032

SUMMARY

Heap buffer out-of-bounds read vulnerability in Avira Antivirus engine when scanning a malformed Windows PE file may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.70.98.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

CVE-2025-14098

SUMMARY

Heap buffer out-of-bounds write vulnerability due to integer overflow in Avira Antivirus engine when scanning a malformed MS-DOS executable file may allow Local Execution of Code or Denial-of-Service of the antivirus engine process. This issue affects Avira Antivirus on Windows, macOS, and Linux for engine builds before 8.3.70.104.

Published

Date2026-06-12

Updated

Date2026-06-12

RISK INFORMATION (Score: 7.8)

cvss3

Base Score: 7.8

Complexity: LOW

CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H

Impact Score

5.9

Exploitability

1.8

REFERENCES

https://www.gendigital.com/us/en/contact-us/security-advisories/

Loading…

API

Access Data Using Our API

Get company history

curl -i -X GET 'https://api.rankiteo.com/underwriter-getcompany-history?
linkedin_id=axa' -H 'apikey: YOUR_API_KEY_HERE'

Try It API Documentation Rapid

MEASURE

What Do We Measure ?

Incident

Finding

Grade

Digital Assets

Every week, Rankiteo analyzes billions of signals to give organizations a sharper, faster view of emerging risks. With deeper, more actionable intelligence at their fingertips, security teams can outpace threat actors, respond instantly to Zero-Day attacks, and dramatically shrink their risk exposure window.

These are some of the factors we use to calculate the overall score:

Network SecurityIdentify exposed access points, detect misconfigured SSL certificates, and uncover vulnerabilities across the network infrastructure.

SBOM (Software Bill of Materials)Gain visibility into the software components used within an organization to detect vulnerabilities, manage risk, and ensure supply chain security.

CMDB (Configuration Management Database)Monitor and manage all IT assets and their configurations to ensure accurate, real-time visibility across the company's technology environment.

Threat IntelligenceLeverage real-time insights on active threats, malware campaigns, and emerging vulnerabilities to proactively defend against evolving cyberattacks.

Rankiteo

By Rankiteo

★ ★ ★ ★ ★

View on G2.com

Rankiteo is a unified scoring and risk platform that analyzes billions of signals weekly to help organizations gain faster, more actionable insights into emerging threats. Empowering teams to outpace adversaries and reduce exposure.

View latest plans →View all security reports →

MILESTONEG

Users
Love Us

Loading…